You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 微創醫療漲7% Microport NeuroTech引入CICC等6名投資者 涉資1.5億美元
格隆匯 11-12 11:07
格隆匯11月12日丨微創醫療(0853.HK)漲7.34%,報38.75港元,總市值705億港元。微創醫療公佈,於2021年11月10日,Microport NeuroTech Limited(目標公司)、該公司全資附屬公司MicroPort Scientific Investment Lt、目標附屬公司保證人(MicroPort NeuroTech International、MicroPort NeuroTech Medical、微創神通醫療科技上海及上海神晶)及該等投資者訂立該協議,該等投資者同意認購約203.25萬股新發行A輪優先股,總代價約為3126萬美元;及附屬公司同意向該等投資者轉讓目標公司約772.04萬股普通股,代價約為1.19億美元,緊隨該等交易完成後,目標公司所轉讓普通股將重新分類及重新指定為A輪優先股。於該等交易完成後,目標公司投資後估值將達約17.5億美元。公吿稱,本次增資及引入新投資者將為目標集團帶來進一步加強其產品研發和市場開拓所需的資金,從而有助於目標集團更好地提升其市場競爭力、拓寬市場資源,並促進快速發展。同時,本次增資及引入新投資者亦有利於進一步提升集團的品牌影響力及市場價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account